Fundraising Fox
MultiplexDX
Slovakia, SK · Founded 2015 · 44 employees on LinkedIn · 4 known investors
Find your way into MultiplexDX
Sign up to see every warm intro you have to MultiplexDX
- Paths you didn't know you had: your email and LinkedIn already hold routes to the MultiplexDX team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
MultiplexDX develops a molecular diagnostics platform for cancer detection using proprietary technologies that combine histopathology, biomarker quantification, and gene expression analysis. The company serves research institutions and clinical laboratories internationally, with a focus on improving diagnostic accuracy in oncology.
Founders & leadership
MultiplexDX was founded in 2015 by Dr. Pavol Cekan.
Investors · 4
Frequently asked questions
- What does MultiplexDX do?
- MultiplexDX develops a molecular diagnostics platform for cancer detection using proprietary technologies that combine histopathology, biomarker quantification, and gene expression analysis. The company serves research institutions and clinical laboratories internationally, with a focus on improving diagnostic accuracy in oncology.
- Who founded MultiplexDX?
- MultiplexDX was founded by Dr. Pavol Cekan in 2015.
- Who are MultiplexDX's investors?
- MultiplexDX's investors include Neulogy Ventures, Crowdberry, Lumus Investments SPV, Venture to Future Fund.
- Where is MultiplexDX headquartered?
- MultiplexDX is headquartered in Slovakia, SK.